Company Ticker News March 18, 2022New Patent Lawsuit Adds to Litigation Worries for Moderna Stock 0 0 Share
Company Ticker News March 18, 2022Moderna requests emergency approval for a second Covid booster for all adults 0 0 Share
Company Ticker News March 18, 2022Moderna Asks FDA to Authorize Second COVID Booster for All Adults 0 0 Share
Company Ticker News March 18, 2022Health Canada Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years 0 0 Share
Company Ticker News March 18, 2022Moderna CEO sold more than $400 million in company stock during pandemic 0 0 Share
Press Release March 18, 2022Moderna Submits Amendment to the Emergency Use Authorization for an Additional Booster Dose of its COVID-19 Vaccine in the U.S. 0 0 Share
Press Release March 18, 2022Moderna Submits Amendment to the Emergency Use Authorization for an Additional Booster Dose of its COVID-19 Vaccine in the U.S. 0 0 Share
Company Ticker News March 18, 2022Moderna seeks FDA approval for fourth dose of COVID vaccine for all adults 0 0 Share